1 active not recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
Follow Neovascularization: new trials by email Literature Review of Neovascularization trials Research Report on Neovascularization
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| KDR2-2 Suspension Eyedrop in the Treatment of Neovascular Glaucoma (KDR-NVG) Trial 4mg/ml KDR2-2 suspension eyedrop, 16mg/ml KDR2-2 suspension eyedrop - Neovascular Glaucoma, Neovascularization | Phase 1 | Active not recruiting | Sun Yat-sen University | 40 | 2021-04-19 | 2024-12-11 |
Glaucoma, Neovascular (1) · Neovascularization, Pathologic (1)
Eye Diseases (1) · Glaucoma (1) · Metaplasia (1) · Ocular Hypertension (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
China (1)